Walleye Capital LLC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 25 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Walleye Capital LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$2,0000.0%21,811
+68.5%
0.00%–
Q1 2022$2,000
-50.0%
12,9480.0%0.00%–
Q4 2021$4,000
-84.0%
12,948
-60.7%
0.00%
-100.0%
Q3 2021$25,000–32,948–0.00%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q3 2021.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders